CESPIATI, ANNALISA

CESPIATI, ANNALISA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 26 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Portal hypertension-like pattern in coronavirus disease 2019 acute respiratory distress syndrome 2024 Dondossola, DanieleZanella, AlbertoLombardi, RosaScaravilli, VittorioLa Mura, VincenzoGrasselli, GiacomoFracanzani, AnnaCespiati, AnnalisaTodaro, SerenaDi Feliciantonio, MariannaGuzzardella, Amedeo + Article (author) -
The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes 2024 Cespiati, AnnalisaSmith, DanielLombardi, RosaFracanzani, Anna Ludovica Article (author) -
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 2024 A. LombardiS. VillaM. ColaneriG. ScaglioneF. BaiB. VariscoV. BonoG. VieroM. ManteroF. PeyvandiG. MarchettiA. GoriA. BanderaS. BosariL. ValentiD. MangioniR. UngaroV. CastelliE. PalombaC. A. PeriP. SaltiniV. PastoreA. LiparotiT. MuheberimanaA. GiommiC. BobbioR. GualtierottiE. PagliaroC. MassimoM. De CaroA. GiachiN. MontanoB. VigoneC. BellocchiA. CarandinaE. TobaldiniF. BlasiS. AlibertiM. SpottiL. TerranovaS. MisuracaM. ContariniL. MorlacchiA. GramegnaM. PappaletteraA. BuscemiM. VicenziG. CostantinoM. SolbiatiL. FurlanA. FaninM. PassarellaV. MonzaniF. BilliS. AccordinoD. MairaN. ScaramelliniA. L. FracanzaniR. LombardiA. CespiatiM. CesariM. ProiettiL. CalcaterraG. GrasselliS. Harari + Article (author) -
Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors 2024 Lombardi, RosaCespiati, AnnalisaFrancione, PaoloDel Zanna, ElenaOrsi, EmanuelaGrancini, ValeriaFargion, SilviaFracanzani, Anna Ludovica + Article (author) -
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 2024 Alfieri, Carlo MariaMolinari, PaoloCinque, FeliceCespiati, AnnalisaBignamini, DanielaNardelli, LucaFracanzani, Anna LudovicaCastellano, GiuseppeLombardi, Rosa + Article (author) -
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 2024 Franchi, CarlottaPeyvandi, FloraScaramellini, NataliaLeoni, SimonaLeoni, SimonaFabrizi, MaddalenaMartelengo, MirianaVigani, GiuliaNegro, EnricaBrenna, MartinoSquintani, Giovanni LorenzoFracanzani, Anna LudovicaCespiati, AnnalisaCinque, FeliceColavolpe, LuciaAlletto, FrancescaScaramellini, NataliaLeoni, SimonaDi Mauro, Alessandra DanutaBenzoni, GianpaoloPeyvandi, FloraAgosti, PasqualePagliaro, EricaSemproni, EleonoraHarari, Sergio + Article (author) -
Nutritional and Lifestyle Therapy for NAFLD in People with HIV 2023 Cinque, FeliceCespiati, AnnalisaLombardi, Rosa + Article (author) -
The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value 2023 Paolini, ErikaLongo, MiriamMeroni, MaricaTria, GiadaCespiati, AnnalisaLombardi, RosaBadiali, SaraFracanzani, Anna LudovicaDongiovanni, Paola + Article (author) -
Anemia management and transfusion strategy in internal medicine units: Less is more 2023 Blanca, DeborahCeriani, GiulianaCespiati, AnnalisaGhigliazza, GabrieleMaira, DilettaOberti, GiovannaScaramellini, NataliaSchinco, Giuseppina LuisaTafuri, FrancescoMontano, NicolaCappellini, Maria DomenicaMotta, Irene + Article (author) -
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians 2023 Cespiati, AnnalisaCinque, FeliceMeroni, MaricaLombardi, RosaDongiovanni, PaolaFracanzani, Anna Ludovica Article (author) -
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population 2023 Cespiati, AnnalisaFracanzani, Anna LudovicaLombardi, Rosa + Article (author) -
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 2022 Baselli, Guido APelusi, SerenaMalvestiti, FrancescoCherubini, AlessandroDongiovanni, PaolaCespiati, AnnalisaD'Ambrosio, RobertaVaira, ValentinaFracanzani, Anna LValenti, Luca Vc + Article (author) -
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies 2022 Cespiati A.Meroni M.Lombardi R.Oberti G.Dongiovanni P.Fracanzani A. L. Article (author) -
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 2022 Cinque F.Cespiati A.Lombardi R.Costantino A.Maffi G.Alletto F.Colavolpe L.Francione P.Oberti G.Fatta E.Bertelli C.Sigon G.Dongiovanni P.Vecchi M.Fargion S.Fracanzani A. L. Article (author) -
Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension 2022 Lombardi, RosaCespiati, AnnalisaFracanzani, Anna L. + Article (author) -
Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity 2022 Lombardi, RosaMura, Vincenzo LaCespiati, AnnalisaIuculano, FedericaSigon, GiordanoPallini, GiadaProietti, MarcoMotta, IreneMontinaro, BeatriceFiorelli, ElisaCesari, MatteoBandera, AlessandraValenti, LucaPeyvandi, FloraMontano, NicolaFracanzani, Anna Ludovica + Article (author) -
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 2021 Rossio R.Harari S.Mannucci P. M.Bandera A.Peyvandi F.Bosari S.Valenti L.Gori A.Lombardi A.Palomba E.Peri C. A.Saltini P.Viero G.Liparoti A.Gualtierotti R.Pagliaro E.Massimo C.De Caro M.Giachi A.Montano N.Vigone B.Bellocchi C.Carandina A.Fiorelli E.Tobaldini E.Blasi F.Mantero M.Morlacchi L.Gramegna A.Buscemi A.Vicenzi M.Costantino G.Solbiati M.Furlan L.Mancarella M.Motta I.Scaramellini N.Fracanzani A. L.Lombardi R.Cespiati A.Cesari M.Proietti M.Cerizza A.Grasselli G. + Article (author) -
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) 2021 Cespiati, AnnalisaLombardi, RosaBertelli, CristinaPisano, GiuseppinaFatta, ErikaSigon, GiordanoIuculano, FedericaFrancione, PaoloFargion, SilviaFracanzani, Anna Ludovica + Article (author) -
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 2021 Bandera A.Harari S.Bosari S.Mannucci P. M.Dell'Orto S.Valenti L.Gori A.Mangioni D.Lombardi A.Ungaro R.Iannotti N.Palomba E.Fortina V.Peri C. A.Saltini P.Viero G.Liparoti A.Muheberimana T.Giommi A.Peyvandi F.Gualtierotti R.Rossio R.Pagliaro E.Massimo C.De Caro M.Montano N.Vigone B.Bellocchi C.Carandina A.Fiorelli E.Tobaldini E.Blasi F.Aliberti S.Misuraca S.D'Adda A.Morlacchi L.Gramegna A.Pappalettera M.Buscemi A.Vicenzi M.Costantino G.Solbiati M.Furlan L.Mancarella M.Fanin A.Passarella M.Monzani V.Billi F.Accordino S.Maira D.Motta I.Scaramellini N.Fracanzani A. L.Lombardi R.Cespiati A.Cesari M.Proietti M.Coppola C.Cerizza A.Grasselli G.Rossi M. + Article (author) -
MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality? 2021 Lombardi, RosaCespiati, AnnalisaFrancione, PaoloCinque, FeliceFargion, SilviaFracanzani, Anna Ludovica Article (author) -